[Abstract] Dipeptidylpeptidases (DPPs) are serine proteases, which cleave small proteins and peptides possessing a proline or an alanine in the second position of their N-terminus. Among the members of this family, dipeptidylpeptidase 4 (DPP4) is constitutively expressed in the extracellular space. DPP4 is found at the surface of many hematopoietic and non-hematopoietic cells and is also present in many biological fluids in a bioactive soluble form. DPP4 expression is modulated by inflammation, and measurements of its activity have been used as biomarker for disease. Here, we describe a method to evaluate the enzymatic activity of DPP4 in vitro and in vivo.
[Background] The magnitude of the enzymatic activity of DPPs can be an indicator of inflammation;
and an important pharmacodynamics parameter for usage of DPP4 inhibitors. Here, we report details for the usage of a commercially available kit to evaluate DPP-enzymatic activity in vitro; and provide details on the generation of biological samples tested. Furthermore, we describe how this method can be used for evaluation of DPP activity in vivo.
Materials and Reagents
1. 96 well plates, U bottom (Fisher Scientific, 2. Luminometer 96 well plates (Promega, catalog number: Z3291) 3. 2 ml Eppendorf tube (Fisher Scientific, 4. 1 ml syringe (BD, catalog number: 309659) 5. 20 G (0.9 x 25 mm) needle (BD, catalog number: 305175) 6. Luciferase-expressing transgenic mouse such as the FVB-Tg(CAG-luc,-GFP)L2G85Chco/J 
Procedure
A. Measuring DPP4 activity in vitro 1. The protocol to measure DPP4 enzymatic activity was performed as described by Promega (provider of the DPP4 enzymatic activity kit used in our assays). Briefly, this assay provides a DPP4-sensitive substrate (Gly-Pro-aminoluciferin) that produces a luminescent signal upon reaction with dipeptidylpeptidases (DPP) and luciferase. DPP-mediated truncation of the GlyPro dipeptide is necessary for this reaction, and therefore the luminescent signal is indicative of DPP enzymatic activity. Important considerations concern the preparation and dilutions of biologic samples used in these assays:
a. Mouse serum and plasma samples should be used at 1 to 20 dilution in Prionex solution.
b. Mouse tumors homogenates should be used at 1 to 2 and 1 to 10 dilution in Prionex solution.
Note: Please refer to the notes at the end of the protocol for instructions on how to obtain tumor homogenates.
c. Peritoneal washes (collected with 1 ml of sterile cold PBS) should be used at 1 to 2 dilution in Prionex solution.
d. A standard curve should be performed using dilutions of recombinant human DPP4 in Prionex solution. Start at 50 ng/ml and perform 2 fold dilutions until 0.01 ng/ml. e. Tumor lysates are generated by high speed shaking, using the TissueLyser II. Speed used is 25 Hz for 2 min. Repeat this step 2 times. The machine should be placed in a cold room.
From this moment on, keep the samples on ice at all times.
f. Centrifuge tubes in an Eppendorf centrifuge at 500 x g for 10 min, at 4 °C. recommend the mice to be sacrificed in a CO2 chamber, as cervical dislocation might result in internal organ damage and bleeding into the peritoneal cavity.
b. Disinfect the skin of the mouse with ethanol and cut it. Expose the entire peritoneal area, without damaging the peritoneal membrane.
c. Inject 1 ml of cold 1x PBS, into the peritoneal cavity using a 1 ml syringe with a 20 G (0.9 x 25 mm) needle. We recommend the injection to be performed through the abdominal fat pads in order to reduce the probability of damaging organs. 
B. Measuring DPP activity in vivo
The luciferin/luciferase system used to measure DPP activity in vitro can also be used to detect DPP activity in vivo, as follows:
1. Inject 50 μl of 10 nM Gly-Pro-aminoluciferin (provided by the Promega kit) into a luciferase expressing mouse, such as the FVB-Tg(CAG-luc) mice. Injection can be intravenous or intraperitoneal. Intravenous injection results in fast systemic delivery (within 5 min, see Figure   1 ), while intraperitoneal injection results in luminescence detected in the peritoneal cavity area (Barreira da Silva et al., 2015) . ).
2. Place the mouse in a XENOGEN (IVIS System) and image luminescence 3-5 min after injection.
The mouse should be anesthetized during the entire procedure, using an isoflurane-based anesthesia system, as specified for each research institution. For image acquisition, test different exposure times (start with 1 sec, up to 1 min).
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Data analysis
1. It is important to keep in mind that this assay detects the activity DPP4, but other members of the DPP family may also truncate Gly-Pro-aminoluciferin. In mouse serum or plasma samples, at least 95% of the measured DPP activity corresponds to DPP4, as evaluated by comparing samples from wildtype and dpp4 -/-mice. Whenever evaluating the specific contribution of DPP4 in other biologic samples (e.g., tumor lysates), we advise assaying the sample in duplicate and adding a DPP4 inhibitor (such as K579) to one of the two samples. The reason behind this additional control is that there are other DPP family members (such as Fibroblast Activating
Protein [FAP] and intracellular DPP8 and 9) that might become exposed after tissue lysis, giving positive signals in the assay. K579 inhibits the activity of DPP4 at concentrations of 50 nM.
Samples do not need to be incubated at length with K579, as inhibition with these concentrations occurs as soon as the reagents are mixed together. It is recommended to perform the assay using at least 4 biological replicates (e.g., biological samples from 4 mice) and 2 technical replicates per sample. 3. Detection of DPP4 activity in the entire body of the mouse can be done following intravenous injection of the Gly-Pro-aminoluciferin. This method can be used to study pharmacodynamics of DPP4 inhibition in vivo, following administration of DPP4 inhibitors, such as sitagliptin ( Figure   1 ). Moreover, it is likely that this technique can be extrapolated to measure DPP4 activity in restricted tissues, such as inoculated luciferase-expressing tumors or transferred immune cells.
It is recommended to perform the assay in at least 3 biological replicates.
Recipes

Prionex solution -Prepare fresh for each experiment
1x PBS supplemented with 0.1% Prionex
